Follow
Selin Oncul
Selin Oncul
Postdoctoral fellow, The University of Texas, MD Anderson Cancer Center
Verified email at mdanderson.org
Title
Cited by
Cited by
Year
Synthesis, computational molecular docking analysis and effectiveness on tyrosinase inhibition of kojic acid derivatives
G Karakaya, A Türe, A Ercan, S Öncül, MD Aytemir
Bioorganic Chemistry 88, 102950, 2019
602019
Cholesterol-targeted anticancer and apoptotic effects of anionic and polycationic amphiphilic cyclodextrin nanoparticles
G Varan, S Öncül, A Ercan, JM Benito, CO Mellet, E Bilensoy
Journal of pharmaceutical sciences 105 (10), 3172-3182, 2016
442016
Synthesis and Cytotoxic Evaluation of Kojic Acid Derivatives with Inhibitory Activity on Melanogenesis in Human Melanoma Cells
G Karakaya, A Ercan, S Oncul, A Mutlu
Anticancer Agents Med Chem, 2018
302018
Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum
S Oncul, P Amero, C Rodriguez-Aguayo, GA Calin, AK Sood, ...
RNA biology 17 (11), 1523-1534, 2020
282020
The interaction between the complement system and hemostatic factors
S Oncul, V Afshar-Kharghan
Current opinion in hematology 27 (5), 341-352, 2020
272020
Discrimination of the effects of doxorubicin on two different breast cancer cell lines on account of multidrug resistance and apoptosis.
S Oncul, A ERCAN
Indian Journal of Pharmaceutical Sciences 79 (4), 2017
162017
A kojic acid derivative promotes intrinsic apoptotic pathway of hepatocellular carcinoma cells without incurring drug resistance
S Oncul, G Karakaya, M Dilsiz Aytemir, A Ercan
Chemical Biology & Drug Design 94 (6), 2084-2093, 2019
152019
Global omics strategies to investigate the effect of cyclodextrin nanoparticles on MCF-7 breast cancer cells
A Ercan, M Çelebier, G Varan, S Öncül, M Nenni, O Kaplan, E Bilensoy
European Journal of Pharmaceutical Sciences 123, 377-386, 2018
132018
Exposure of hepatocellular carcinoma cells to Ankaferd Blood Stopper® alters cell death signaling networks confirmed by oncoproteomic and genomic profiling studies
M Nenni, S Öncül, A Ercan, M Çelebier, İ Süslü, İC Haznedaroğlu
Current Traditional Medicine 7 (2), 246-258, 2021
92021
Polycationic cyclodextrin nanoparticles induce apoptosis and affect antitumoral activity in HepG2 cell line: An evaluation at the molecular level
A Ercan, M Çelebier, S Oncul, G Varan, E Kocak, JM Benito, E Bilensoy
International Journal of Pharmaceutics 598, 120379, 2021
82021
HGF-1 proliferation on titanium dental implants treated with laser melting technology
O Arifagaoglu, S Oncul, A Ercan, O Olcay, B Ersu
Nigerian Journal of Clinical Practice 22 (2), 251-257, 2019
82019
Kojic acid derivatives as potential anticancer agents: Synthesis and cytotoxic evaluation on A375 human malignant melanoma cells
G Karakaya, A ERCAN, S ÖNCÜL, M Aytemir
Journal of Research in Pharmacy 23 (4), 2019
82019
RNA Therapeutics: The Evolving Landscape of RNA Therapeutics
PH Giangrande, V De Franciscis, JJ Rossi
Academic Press, 2022
52022
An allomaltol derivative triggers distinct death pathways in luminal a and triple-negative breast cancer subtypes
A Ercan, S Oncul, G Karakaya, M Aytemir
Bioorganic Chemistry 105, 104403, 2020
42020
An investigation of the effect of surface characterization on Saos-2 cell proliferation after coating of titanium alloy surfaces by a selective laser melting process
EO Olcay, A Ercan, S Oncul, O Arifagaoglu, B Ersu
Surface and Coatings Technology 422, 127540, 2021
32021
Karaciğer ve meme kanseri hücreleri ile embriyonik böbrek hücrelerinde doksorubisinin apoptotik genlerin ve MDR-1 geninin ekspresyon düzeylerine etkisi
S Öncül
Sağlık Bilimleri Enstitüsü, 2013
32013
Interactions between platelets and tumor microenvironment components in ovarian cancer and their implications for treatment and clinical outcomes
S Oncul, MS Cho
Cancers 15 (4), 1282, 2023
22023
Pharmacometabolomic assessment of vitamin E loaded human serum albumin nanoparticles on HepG2 cancer cell lines
Y Şenol, O Kaplan, C Varan, N Demirtürk, S Öncül, BB Fidan, A Ercan, ...
Journal of Drug Delivery Science and Technology 79, 104017, 2023
22023
Q-TOF LC/MS-based untargeted metabolomics approach to evaluate the effect of folate-conjugated cyclodextrins on triple-negative breast cancer cells
I Varol, O Kaplan, N Erdoğar, S Öncül, TT Nielsen, A Ercan, E Bilensoy, ...
Current Pharmaceutical Analysis 17 (10), 1272-1281, 2021
22021
Antitumor activity of Ankaferd Blood Stopper® on MCF-7 breast cancer: a proteomic approach to ascertain the mechanism of the action
ÖC Zeki, M Nenni, M Celebier, S Öncül, A Ercan, İ Süslü, ...
Journal of Herbal Medicine 28, 100449, 2021
22021
The system can't perform the operation now. Try again later.
Articles 1–20